Hypertension
Conditions
Keywords
Inflammation, Blood Pressure, High
Brief summary
In addition to high blood pressure, hypertension is characterized by inflammation, which is the body's response to injury or infection. Inflammation has been found to cause plaque formation on artery walls. This study will compare the effect of an exercise program versus a combined exercise and diet program on reducing inflammation in hypertensive individuals.
Detailed description
Hypertension is characterized by high blood pressure, as well as by inflammation and increased adhesion among blood cells. Inflammation may play an important role in atherosclerosis, which involves the build up of fatty deposits on the inside wall of arteries. Pharmacological treatment for hypertension successfully reduces blood pressure. However, it has limited effectiveness for reducing the associated inflammation. Losing weight and increasing physical activity have been shown to reduce general inflammation, but more research is needed to determine their effect on inflammation that is directly related to hypertension. The purpose of this study is to evaluate the effectiveness of an exercise program versus a combined exercise and diet program at reducing inflammation and cell adhesion in hypertensive individuals. This study will enroll inactive and overweight hypertensive individuals. Participants will be randomly assigned to a 12-week exercise program, a 12-week combined exercise and diet program, or a non-intervention group. At study entry, participants will take part in a speech stressor task, a VO2 peak exercise test, and an exercise treadmill test. During the speech stressor task, participants will be videotaped while they talk about potentially stressful situations. Prior to and following the speech task, blood will be collected, blood pressure and heart rate will be recorded, and standardized questionnaires will be completed to assess anger, anxiety, and stress levels. The two exercise tests will occur within 5 days of each other and both will involve running on a treadmill. Heart rate, respiratory rate, and physical activity intensity will be monitored; heart activity will be measured by an electrocardiogram (ECG). Blood will be collected at various times during the testing procedures to measure levels of inflammation biomarkers, including C-reactive protein (CRP) and white blood cells. Perceived exertion and stress levels will also be assessed. Participants in the exercise intervention will receive a 12-week membership to the YMCA and will meet with a personal trainer twice a week. They will be encouraged to exercise on their own for an additional 3 to 4 days per week. Participants will also be provided with a pedometer, which will track the number of steps they take each day. Participants in the diet program will meet with a dietician and will be encouraged to reduce their caloric intake by incorporating low-fat, high-fiber foods into their diet. Throughout the study, participants will have regular follow-up phone calls with study staff and meetings with their personal trainer and/or dietician to ensure that they are adhering to their assigned program. At the end of 12 weeks, participants will return for a repeat speech stressor task, a VO2 peak exercise test, and an exercise treadmill test. Participants in the non-intervention group will then be assigned to either the exercise program or combined exercise and diet program.
Interventions
BEHAVIORALExercise Program
Participants in the exercise group will receive a 12-week membership to the YMCA and will meet with a personal trainer twice a week. They will be encouraged to exercise on their own for an additional 3 to 4 days per week. Participants will also be provided with a pedometer, which will track the number of steps they take each day.
BEHAVIORALCombined Exercise and Diet Program
Participants in this group will receive a 12-week membership to the YMCA and will meet with a personal trainer twice a week. They will be encouraged to exercise on their own for an additional 3 to 4 days per week. Participants will also be provided with a pedometer, which will track the number of steps they take each day. They will meet with a dietician and will be encouraged to reduce their caloric intake by incorporating low-fat, high-fiber foods into their diet.
Sponsors
National Heart, Lung, and Blood Institute (NHLBI)
University of California, San Diego
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
25 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
* Unmedicated hypertension with blood pressure greater than 140/90 mm Hg but less than 175/104 mm Hg * Body mass index (BMI) of 23.5 to 34 * Relatively inactive, as defined by the Leisure Time Exercise Questionnaire * Willing and able to participate in the assigned study group * Postmenopausal women not on hormone replacement therapy (HRT) and premenopausal women
Exclusion criteria
* Abnormal echocardiogram * Recent stroke or significant brain impairment * Current psychiatric disease * History of psychosis or major depression * Currently taking psychotropic drugs * Currently taking any medications (e.g., anti-inflammatory medications) other than antihypertensives (which will be tapered) * Current drug and/or alcohol abuse * Consumes more than 600 mg of caffeine per day * Diabetes * Congestive heart failure * Bronchospastic pulmonary disease * History of heart attacks * Known secondary high blood pressure * Angina * History of life-threatening arrhythmias * History of kidney damage * Current participation in regular or structured exercise classes, or regular physical exercise in the 6 months prior to study entry * Inability to perform moderate to vigorous intensity exercise * Current participation in a diet * High blood pressure, only when measured in a doctor's office (i.e., white coat hypertension) * Arthritis, exertional asthma, or any other disorder likely to be made worse by exercise * Pregnant
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Peripheral blood mononuclear cell chemotaxis | Measured at 4 years |
| Leukocyte CD11a expression | Measured at 4 years |
| Leukocyte CD11b expression | Measured at 4 years |
| Leukocyte activation | Measured at 4 years |
| CRP | Measured at 4 years |
| Interleukin-6 (IL-6) | Measured at 4 years |
| Tumor necrosis factor-alpha (TNF-alpha) | Measured at 4 years |
| Soluble intercellular adhesion molecule-1 (sICAM-1) | Measured at 4 years |
| SE-selectin | Measured at 4 years |
Secondary
| Measure | Time frame |
|---|---|
| Weight | Measured at 4 years |
| Blood pressure | Measured at 4 years |
| Physical fitness | Measured at 4 years |
Countries
United States
Outcome results
None listed